TRVNTREVENA INC

Nasdaq trevena.com


$ 0.35 $ 0.01 (2.94 %)    

Friday, 19-Apr-2024 11:25:29 EDT
QQQ $ 418.31 $ -4.81 (-1.14 %)
DIA $ 379.25 $ 0.77 (0.2 %)
SPY $ 497.72 $ -1.71 (-0.34 %)
TLT $ 89.05 $ -0.31 (-0.35 %)
GLD $ 221.54 $ 1.52 (0.69 %)
$ 0.366
$ 0.34
$ 0.00 x 0
$ 0.00 x 0
$ 0.34 - $ 0.35
$ 0.30 - $ 3.28
1,241,939
na
4.66M
$ 0.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-01-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 03-09-2021 12-31-2020 10-K
14 11-02-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 03-12-2020 12-31-2019 10-K
18 11-04-2019 09-30-2019 10-Q
19 08-07-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-13-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-02-2018 06-30-2018 10-Q
24 05-03-2018 03-31-2018 10-Q
25 03-07-2018 12-31-2017 10-K
26 11-07-2017 09-30-2017 10-Q
27 08-03-2017 06-30-2017 10-Q
28 05-04-2017 03-31-2017 10-Q
29 03-08-2017 12-31-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-Q
33 03-09-2016 12-31-2015 10-K
34 11-10-2015 09-30-2015 10-Q
35 08-11-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 03-18-2015 12-31-2014 10-K
38 11-12-2014 09-30-2014 10-Q
39 08-12-2014 06-30-2014 10-Q
40 05-09-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-trevena-maintains-9-price-target

HC Wainwright & Co. analyst Douglas Tsao maintains Trevena (NASDAQ:TRVN) with a Buy and maintains $9 price target.

 recap-trevena-q4-earnings
Recap: Trevena Q4 Earnings
04/01/2024 13:40:13

 trevena-q4-eps-106-misses-038-estimate-cash-balance-of-33m

Trevena (NASDAQ:TRVN) reported quarterly losses of $(1.06) per share which missed the analyst consensus estimate of $(0.38) by ...

 hc-wainwright--co-reiterates-buy-on-trevena-maintains-9-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Trevena (NASDAQ:TRVN) with a Buy and maintains $9 price target.

 trevena-granted-us-patent-11912693-titled-compounds-for-modulating-s1p1-activity-and-methods-of-using-the-same

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11912693

 trevena-has-been-granted-us-patent-11912713-titled-7-membered-aza-heterocyclic-containing-delta-opioid-receptor-modulating-compounds-methods-of-using-and-making-for-treating-pain-migraines-depression-parkinsons-disease-and-other-disorders

https://ppubs.uspto.gov/pubwebapp/external.html?q=(11912713).pn

 trevena-inc-announces-4m-concurrent-private-placement-of-2779906-shares-of-common-stock-at-a-price-of-070share-and-warrant-exercise

Trevena Inc. ("Trevena" or the "Company") (NASDAQ:TRVN), a biopharmaceutical company focused on the development...

 why-up-fintech-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket

Shares of UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter.

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 recap-trevena-q3-earnings
Recap: Trevena Q3 Earnings
11/14/2023 12:05:21

 trevena-q3-eps-057-misses-015-estimate-sales-18000k-beat-10000k-estimate-cash-and-cash-equivalents-of-35m-is-expected-to-be-sufficient-to-fund-the-companys-operating-expenses-and-capital-expenditure-requirements-into-q3-2024

Trevena (NASDAQ:TRVN) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.15) by ...

 earnings-preview-trevena
Earnings Preview: Trevena
11/13/2023 17:02:20

 why-alteryx-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reporte...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION